Inventor · disambiguated record
Benito Casu
Also filed as: CASU BENITO
21 granted patents·3 pending applications·341 citations·filing 1980–2010
96Inventor score
Files withCRINOS INDUSTRIA FARMACO5MASSACHUSETTS INST TECHNOLOGY3BAXTER INT2CASU BENITO2SIGMA TAU IND FARMACEUTI2
Top patents by PatentIndex Score
24 records- 0192US8067555B2Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effectCASU BENITO·Filed 2007·Granted Nov 29, 2011·16 cites·8 claims
- 0291US7790700B2Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effectSIGMA TAU IND FARMACEUTI·Filed 2005·Granted Sep 7, 2010·15 cites·25 claims
- 0391US7781416B2Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effectSIGMA TAU RES SWITZERLAND SA·Filed 2005·Granted Aug 24, 2010·20 cites·10 claims
- 0490US7508206B2Method for sequence determination using NMRMASSACHUSETTS INST TECHNOLOGY·Filed 2003·Granted Mar 24, 2009·33 cites·22 claims
- 0588US5008253ASulfoamino derivatives of chondroitin sulfates of dermatan sulfate and of hyaluronic acid and their pharmacological propertiesCRINOS INDUSTRIA FARMACO·Filed 1989·Granted Apr 16, 1991·53 cites·12 claims
- 0682US7737692B2Method for sequence determination using NMRMASSACHUSETTS INST TECHNOLOGY·Filed 2008·Granted Jun 15, 2010·5 cites·38 claims
- 0778US8018231B2Method for sequence determination using NMRMASSACHUSSETTS INST OF TECHNOLOGY·Filed 2010·Granted Sep 13, 2011·3 cites·14 claims
- 0877US8222231B2Derivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effectCASU BENITO·Filed 2010·Granted Jul 17, 2012·3 cites·11 claims
- 0976US4340731APolycarboxyalkyl-cellulose having high fluid absorbing and retaining properties, and process for preparing sameMONTEDISON SPA·Filed 1980·Granted Jul 20, 1982·24 cites·7 claims
- 1075US7728589B2Method for sequence determination using NMRMASSACHUSETTS INST TECHNOLOGY·Filed 2008·Granted Jun 1, 2010·5 cites·18 claims
- 1175US7005508B2Nitroderivatives of polysaccharidesNICOX SA·Filed 2001·Granted Feb 28, 2006·12 cites·27 claims
- 1273US4369256APolyalkylene resins crosslinked with diisocyanate used for selective separation of heparin from other glucosaminoglycanesCRINOS INDUSTRIA FARMACO·Filed 1981·Granted Jan 18, 1983·14 cites·4 claims
- 1372US4432801AProcess for controlled degradation of liquid glucose syrups and cement additive products therefromGRACE ITALIANA SPA·Filed 1981·Granted Feb 21, 1984·32 cites·18 claims
- 1469US5110918AProcess for preparing EDTA-free heparins, heparin fractions and fragmentsSANOFI SA·Filed 1990·Granted May 5, 1992·25 cites·2 claims
- 1568US7208479B2Peritoneal dialysis solution containing modified icodextrinsBAXTER INT·Filed 2004·Granted Apr 24, 2007·3 cites·22 claims
- 1668US6197943B1Glycosaminoglycans having high antithrombotic activityINALCO SPA·Filed 1998·Granted Mar 6, 2001·25 cites·5 claims
- 1767US6770148B1Peritoneal dialysis solution containing modified icodextrinsBAXTER INT·Filed 1998·Granted Aug 3, 2004·19 cites·6 claims
- 1866US5605891AUse of polysaccharides in acute peripheral neuropathiesCRINOS INDUSTRIA FARMACO·Filed 1993·Granted Feb 25, 1997·20 cites·8 claims
- 1961US4411796APolyaminic resin for the selective separation of heparin from other glucosaminoglycanes and method for the preparation thereofCRINOS IND FARMABIOLOG·Filed 1982·Granted Oct 25, 1983·12 cites·4 claims
- 2048US2008139503A1Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effectSIGMA TAU IND FARMACEUTI·Filed 2007·Application pending·0 cites
- 2146US2001044424A1Peritoneal dialysis solution containing modified icodextrinsFiled 2001·Application pending·0 cites
- 2240US2005137167A1Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effectFiled 2001·Application pending·0 cites
- 2335US5152998AProcess for the isolation and purification of monosialoganglioside from a starting lipidic mixture by complexation with alpha-cyclodextrin and related intermediate compoundCRINOS INDUSTRIA FARMACO·Filed 1992·Granted Oct 6, 1992·1 cites·1 claims
- 2431US5108613AProcess for the isolation and purification of monosialoganglioside from a starting lipidic mixture by complexation with alfa-cyclodextrin and related intermediate compoundCRINOS INDUSTRIA FARMACO·Filed 1991·Granted Apr 28, 1992·1 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Benito Casu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →